Vanta Bioscience Ltd Secures Order Valued at Rs. 57 Lakhs

Vanta Bioscience Ltd, a leading player in the bioscience industry, has recently received a substantial order amounting to Rs. 57 Lakh from a well-known Singaporean company. The order entails the execution of Good Laboratory Practice (GLP) Studies, encompassing critical assessments such as the Bacterial Reverse Mutation assay, oral toxicity study, in vitro tests, and various other studies.

These comprehensive studies will be conducted by Vanta Bioscience Ltd at its state-of-the-art research facility located in Gummidipundi, Chennai. The company commits to completing the project within a turnaround time of 26 weeks from the receipt of the requisite test items or any mutually agreed extended period.

This significant order adds to the already impressive order book of Vanta Bioscience Ltd, which currently aggregates to over Rs. 10 Crores, comprising multiple studies received by the company. The successful acquisition of such projects highlights the company's expertise and credibility in the bioscience domain.

After resolving resolution proceedings and regaining absolute control, the promoters and directors of Vanta Bioscience Ltd have redoubled their efforts to revitalize the company financially and operationally. With the unwavering support of the Vanta Bioscience family, employees, and stakeholders, the company aims to increase its market share, turnover, and profits in the forthcoming financial years.

Having regained the confidence of long-term clients from India and abroad, the company is actively working towards securing new clients and reinstating existing ones in its order book. In a strategic move, Vanta Bioscience Ltd is targeting international clients, especially from Japan and Europe, within the next few months. The company has successfully cleared audits from certain international companies, fostering optimism about generating substantial revenue in the coming financial years. This positive development is crucial information for all stakeholders associated with Vanta Bioscience Ltd.

EQUITYBULLS